erlotinib hydrochloride has been researched along with salicylic acid in 3 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (salicylic acid) | Trials (salicylic acid) | Recent Studies (post-2010) (salicylic acid) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 22,864 | 771 | 8,704 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulj, TK; Cetner, AS; Krunic, AL; Villano, JL | 1 |
| Chiu, HC; Chiu, HY | 1 |
| Aerts, JGJV; Braal, CL; de Bruijn, P; Koolen, SLW; Mathijssen, RHJ; Peric, R; Veerman, GDM | 1 |
3 other study(ies) available for erlotinib hydrochloride and salicylic acid
| Article | Year |
|---|---|
Refractory aggressive keratoacanthoma centrifugum marginatum of the scalp controlled with the epidermal growth factor receptor inhibitor erlotinib.
Topics: Aged; ErbB Receptors; Erlotinib Hydrochloride; Female; Head and Neck Neoplasms; Humans; Keratoacanthoma; Protein Kinase Inhibitors; Quinazolines; Scalp; Skin Neoplasms; Treatment Outcome | 2010 |
Scalp pustules in a patient receiving chemotherapy.
Topics: Acneiform Eruptions; Aged; Aged, 80 and over; Biopsy; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Male; Quinazolines; Scalp | 2013 |
Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application.
Topics: Biological Variation, Population; Chromatography, High Pressure Liquid; Cosmetics; Drug Monitoring; Drug Stability; Erlotinib Hydrochloride; Hair; Humans; Limit of Detection; Protein Kinase Inhibitors; Reproducibility of Results; Scalp; Tandem Mass Spectrometry; Time Factors; Ultraviolet Rays | 2019 |